Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing

1 Mar 2024

Abstract excerpt

PURPOSE: Germline genetic testing (GT) is important for prostate cancer (PCA) management, clinical trial eligibility, and hereditary cancer risk. However, GT is underutilized and there is a shortage of genetic counselors. To address these gaps, a patient-driven, pretest genetic education webtool was designed and studied compared with traditional genetic counseling (GC) to inform strategies for expanding access to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Genomics and Rare Diseases
Share to Prostate Cancer Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38452310
DOI: 10.1200/po.23.00552

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline TestingPMID 38452310Read ↗

Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs.Semantic proximity Read ↗

Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled TrialSemantic proximity Read ↗

Germline testing for prostate cancer: current state and opportunities for enhanced accessSemantic proximity Read ↗

eREACH: A randomized trial of digital alternatives to genetic counseling for metastatic cancerSemantic proximity Read ↗

Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients.Semantic proximity Read ↗

Informing models of cancer genetics care in the era of multigene panel testing with patient-led recommendations.Semantic proximity Read ↗

Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.Semantic proximity Read ↗

What tools do men need to make an informed decision about germline genetic testing for prostate cancer? A qualitative and survey studySemantic proximity Read ↗

Interventions to support decision making in people considering germline genetic testing for BRCA 1/2 pathogenic and likely pathogenic variants: A scoping review.Semantic proximity Read ↗

Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary CareSemantic proximity Read ↗

Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service deliverySemantic proximity Read ↗

Patient and provider attitudes toward genomic testing for prostate cancer susceptibility: a mixed method study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.